Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018
Journal of Diabetes · 2024-06 · 16 (6)
DOI: 10.1111/1753-0407.13569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 16.05.2024. Verfasst von Zhiliang Mai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Intra-Abdominal Fat, Muscle, Skeletal, Nutrition Surveys, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major project of collaborative innovation of industry-university-research in Guangzhou, Science and Technology Innovation Committee of Shenzhen.
Abstract (Originalsprache)
Background and Aims Previous studies have shown that sarcopenic obesity (SO) was associated with nonalcoholic fatty liver disease (NAFLD). However, research is limited in the context of the NAFLD renamed as metabolic dysfunction‐associated steatotic liver disease (MASLD) defined by updated diagnostic criteria. The aim of this study was to use the index skeletal muscle mass to visceral fat area ratio (SVR) to describe SO in a large and representative US population (National Health and Nutrition Examination Survey 2017–2018) of adults and investigate their association with MASLD.
Methods
A total of 2087 individuals were included in the analysis. SVR was calculated according to the measurement of dual‐energy x‐ray absorptiometry and MASLD was diagnosed with controlled attenuation parameter scores and cardiometabolic risk factors. SVR was divided into tertiles. Logistic regression adjusted for confounders was used to evaluate the association between SVR and MASLD. Several sensitivity analyses were performed to test the robustness of our findings.
Results
In a multivariate logistic regression analysis, a significant association between SVR and MASLD was shown (odds ratio [OR]: 3.11, 95% confidence interval [CI]: 1.31–7.39, p = .010 for middle levels of SVR; OR: 3.82, 95% CI: 1.45–10.08, p = .007 for lowest levels of SVR). The sensitivity analyses confirmed that the association was robust.
Conclusion
Our findings imply that decreased SVR is linked to MASLD. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
- Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Zhiliang Mai, Yinfei Chen
Förderung
- Major project of collaborative innovation of industry-university-research in Guangzhou
- Science and Technology Innovation Committee of Shenzhen
Zitieren
APA
Mai, Z., Chen, Y., Mao, H., & Wang, L. (2024). Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018. Journal of Diabetes, 16(6). https://doi.org/10.1111/1753-0407.13569
Vancouver
Mai Z, Chen Y, Mao H, Wang L. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018. Journal of Diabetes. 2024;16(6). doi:10.1111/1753-0407.13569
BibTeX
@article{Mai2024,
author = {Mai, Zhiliang and Chen, Yinfei and Mao, Hua and Wang, Lisheng},
title = {Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction‐associated fatty liver disease: A cross‐sectional study of NHANES 2017–2018},
journal = {Journal of Diabetes},
year = {2024},
volume = {16},
number = {6},
doi = {10.1111/1753-0407.13569}
}
EUVIMED